For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying ... up at mealtimes with fast-acting insulins.

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

A long-acting insulin from Novo Nordisk was shown to have a greater risk of excessively lowering patients' blood sugar without offering better management of sugar levels or other benefits ...

Eli Lilly’s big-selling insulin ... In the meantime, Novo Nordisk has responded to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve on the ...

LONDON, Nov 14 (Reuters) - Novo Nordisk ... injecting insulin. Some diabetes patients in the U.S. have this year pushed back against the company's decision to stop selling its long-acting insulin ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. The Danish drugmaker ...

Novo Nordisk, the company behind ... It was a way to get this life-saving drug out in the world fast." Back in Denmark, the Kroghs set up the Nordisk Insulin Company. To keep their agreement ...

Novo Nordisk shares take a hit after a report revealed ... Jens Martin Skibsted and Rasmus Bech Hansen argue. The Race For Insulin Pills, So Diabetics Can Put Their Needles Away One of the ...